Malaysian Genomics to Collaborate on Cannabinoid R&D
Retrieved on:
Friday, February 24, 2023
Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company.
Key Points:
- Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company.
- MAHSA University is a private Malaysian university focused on allied health sciences with a 48-acre campus in Bandar Saujana Putra, Selangor and a diverse population of students from 75 countries.
- Mr. Ken Clement, Chairman and CEO of Kensana Health Canada said, "We look forward to working with Malaysian Genomics and MAHSA by providing our technology and knowledge in advancing the R&D efforts.
- Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
Copyright 2023 ACN Newswire .